Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1.

@article{Kher2014SubstrateDP,
  title={Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1.},
  author={S. Kher and Maria Penzo and Simone Fulle and P. Finn and M. Blackman and A. Jirgensons},
  journal={Bioorganic & medicinal chemistry letters},
  year={2014},
  volume={24 18},
  pages={
          4486-4489
        }
}
  • S. Kher, Maria Penzo, +3 authors A. Jirgensons
  • Published 2014
  • Chemistry, Medicine
  • Bioorganic & medicinal chemistry letters
  • Peptidic α-ketoamides have been developed as inhibitors of the malarial protease PfSUB1. The design of inhibitors was based on the best known endogenous PfSUB1 substrate sequence, leading to compounds with low micromolar to submicromolar inhibitory activity. SAR studies were performed indicating the requirement of an aspartate mimicking the P1' substituent and optimal P1-P4 length of the non-prime part. The importance of each of the P1-P4 amino acid side chains was investigated, revealing… CONTINUE READING
    11 Citations

    Topics from this paper

    The Plasmodium berghei serine protease PbSUB1 plays an important role in male gamete egress
    • 5
    Targeting malaria parasite invasion of red blood cells as an antimalarial strategy
    • 22
    • PDF
    Solution-phase automated synthesis of an α-amino aldehyde as a versatile intermediate
    • 5
    • PDF

    References

    SHOWING 1-10 OF 23 REFERENCES
    Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1.
    • 24
    Rational design of the first difluorostatone-based PfSUB1 inhibitors.
    • 29
    Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors
    • 46
    • PDF
    Novel CADD-based peptidyl vinyl ester derivatives as potential proteasome inhibitors.
    • Ke Mou, Bo Xu, +4 authors P. Xu
    • Chemistry, Medicine
    • Bioorganic & medicinal chemistry letters
    • 2008
    • 14
    Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors.
    • 9